Efficiency of CD19 chimeric antigen receptor-modified T cells for treatment of B cell malignancies in phase I clinical trials: a meta-analysis

Por Zhang, Tengfei, Cao, Ling, Xie, Jing, Shi, Ni, Zhang, Zhen, Luo, Zhenzhen, Yue, Dongli, Zhang, Zimeng, Wang, Liping, Han, Weidong, Xu, Zhongwei, Chen, Hu, Zhang, Yi
Publicado no Oncotarget (2015)